Bacil Pharma - Quaterly Results

16 May 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended March 2023. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -0.76 millions as compared to Net Loss of Rs. -37.37 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to -0.75% as compared to -37.36% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.09 0.08 12.50 1.15 0.58 98.28 1.15 0.58 98.28
PBIDT -0.75 -37.36 -97.99 -0.99 -38.56 -97.43 -0.99 -38.56 -97.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.75 -37.36 -97.99 -0.99 -38.56 -97.43 -0.99 -38.56 -97.43
Depreciation 0.01 0.01 0.00 0.03 0.04 -25.00 0.03 0.04 -25.00
PBT -0.76 -37.37 -97.97 -1.02 -38.60 -97.36 -1.02 -38.60 -97.36
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.76 -37.37 -97.97 -1.02 -38.60 -97.36 -1.02 -38.60 -97.36
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

61.31 -1.25 (-2.00%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.